Incorporating PARP-inhibitors into clinical routine: A tailored treatment strategy to tackle ovarian cancer. [electronic resource]
Producer: 20170706Description: 6-11 p. digitalISSN:- 2295-3337
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.